FATE
FATE THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
FATE THERAPEUTICS INC (FATE) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$18.50M; the largest are Renaissance Technologies, Izzy Englander, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 added. 1 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders41 also report options
Congress trades1
Price$2.38vs quarter-end-11.85%
Sectors0
This quarter's moves
Top holderNew1
Added2
Trimmed / sold0
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $8.05M0.0% of portfolio2,983,2682026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Renaissance Technologies | $8.05M | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $242.7K— of portfolio89,9002026 Q2
Value $28.1K— of portfolio10,4002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $242.7K | — | — |
| Ken GriffinPUT | $28.1K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.